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Cholesterol ester (CE)-laden macrophage foam cells
are thehallmarkof atherosclerosis, and thehydrolysis
of intracellular CE is one of the key steps in foam cell
formation. Although hormone-sensitive lipase (LIPE)
and cholesterol ester hydrolase (CEH), which is
identical to carboxylsterase 1 (CES1, hCE1), were
proposed to mediate the neutral CE hydrolase
(nCEH) activity in macrophages, recent evidences
have suggested the involvement of other enzymes.
We have recently reported the identification of a
candidate, neutral cholesterol ester hydrolase 1
(Nceh1). Here we demonstrate that genetic ablation
ofNceh1promotes foamcell formation and thedevel-
opmentof atherosclerosis inmice.We furtherdemon-
strate that Nceh1 and Lipe mediate a comparable
degree of nCEHactivity inmacrophages and together
account for most of the activity. Mice lacking both
Nceh1 and Lipe aggravated atherosclerosis in an
additive manner. Thus, Nceh1 is a promising target
for the treatment of atherosclerosis.
INTRODUCTION
Atherosclerotic cardiovascular diseases are the leading causes
of mortality in industrialized countries, despite advances in the
management of coronary risk factors. Heart attacks arise from
the thrombotic occlusion of coronary arteries following the
rupture of plaques. Lipid-rich plaques, which are characterized
by a plethora of cholesterol ester (CE)-laden macrophage foam
cells, are prone to rupture (Libby, 2002). The hydrolysis of intra-
cellular CE is the initial step of reverse cholesterol transport
(RCT) (Brown et al., 1979). As the hydrolysis of CE preceding
RCT takes place at neutral pH, the enzymes catalyzing it have
been collectively called neutral CE hydrolases (nCEHs) to distin-
guish them from lysosomal acid lipase, the CE hydrolase in lyso-
somes whose optimal pH is acidic. Since this step is rate-limiting
particularly in macrophage foam cells (Ishii et al., 1992; Krithar-Cell Mides et al., 1998), it is important to clarify the mechanisms that
mediate the hydrolysis of CE in foam cells.
Todate, threeenzymeshavebeenproposed toserveasnCEHs
in macrophages: hormone-sensitive lipase (LIPE) (Yeaman,
2004); cholesteryl ester hydrolase (CEH)(Ghosh, 2000), which is
identical to human liver carboxylesterase1 (CES1, hCE-1) (Long
et al., 1991) or macrophage serine esterase1 (HMSE1) (Munger
et al., 1991), also known as a human ortholog of triacylglycerol
hydrolase (TGH) (Lehner and Vance, 1999); and neutral choles-
terol ester hydrolase 1(Nceh1, MGI ID 2443191) (Okazaki et al.,
2008), which is also known asKIAA1363 or arylacetamide deace-
tylase-like 1 (Aadacl1) (Nomura et al., 2005). Lipe is expressed in
macrophages, and its overexpression inhibits the accumulation
of CE in THP-1 macrophages (Escary et al., 1998; Okazaki
et al., 2002). However, peritoneal macrophages (MPMs) of
Lipe-deficient (Lipe/) mice in a mixed genetic background still
retain substantial nCEH activity (Osuga et al., 2000), indicating
the presence of additional nCEH(s). Ghosh reported CES1 as
a promising candidate for an nCEH, because its macrophage-
specific overexpression driven by the promoter of macrophage
scavenger receptor-1 protected against diet-induced athero-
sclerosis in low-density-lipoprotein receptor (Ldlr)-deficient
(Ldlr/) mice (Zhao et al., 2007). However, the effects of loss of
function of CES1 on nCEH activity in macrophages have not
been reported. Furthermore, a mouse ortholog of CES1, TGH,
was expressed at a low level in MPMs (Okazaki et al., 2008) and
possessed negligible nCEH activity (Okazaki et al., 2006).
In contrast, Nceh1 is robustly expressed in MPMs as well as in
atherosclerotic lesions. Its overexpression inhibits the accumula-
tion of CE in THP-1 macrophages and the knockdown of Nceh1
by short interference RNA significantly reduced nCEH activity in
MPMs (Okazaki et al., 2008). Therefore, Nceh1 is more likely to
be involved in the hydrolysis of CE inMPMs. In the present study,
we took advantage of gene targeting to underscore the impor-
tance of Nceh1 as well as Lipe in the atherogenesis.
RESULTS
Nceh1 Mediates nCEH Activity in Macrophages
The targeting strategy was designed so that exon 4, which
encodes the catalytic domain, of the endogenous Nceh1 geneetabolism 10, 219–228, September 2, 2009 ª2009 Elsevier Inc. 219
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S1A and S1B). Analysis of progeny showed that mice heterozy-
gous (+/) and homozygous (/) with respect to the disrupted
Nceh1 allele were born in numbers consistent with Mendelian
inheritance of the mutant allele, survived normally, and were
fertile. Nceh1-deficient (Nceh1/) mice maintained on normal
chow exhibit a normal metabolic phenotype (Table S1).
To elucidate the contribution of Nceh1 to the nCEH activity
in macrophages, MPMs were examined in vitro. Successful
deletion of Nceh1 was confirmed at both the protein and
mRNA levels (Figures S1C and S1D). Nceh1 deficiency reduced
nCEH activity by 50%, and triacylglycerol lipase (TGL) activity by
20%, respectively (Figure 1A).
Consistent with our previous report that Nceh1 is amicrosomal
enzyme (Igarashi et al., 2009), Nceh1 deficiency selectively
reduced the microsomal nCEH activity but did not affect the
cytosolic nCEH activity (Figure 1B).
Nceh1 Is Involved in Foam Cell Formation
Foam cells were produced in vitro by incubation of MPMs with
acetylated LDL (acLDL). The incubation with an increasingly
higher concentration of acLDL resulted in an increase in intracel-
lular CE content by 50% in Nceh1/ macrophages compared
Figure 1. nCEH Activity and Cholesterol Traf-
ficking in Nceh1/ Macrophages
(A) Peritoneal macrophages (n = 7–8) were incubated with
DMEM containing 10% FCS. Neutral cholesterol ester
hydrolase (nCEH) activity or triglyceride lipase (TGL)
activity of whole-cell lysates were measured.
(B) The nCEH activity after subcellular fractionation (n = 8).
(C)Intracellular levels of cholesterol ester (CE) or free
cholesterol (FC) inmacrophages. Peritoneal macrophages
(n = 7–8) were incubated with increasing concentrations
of acLDL for 24 hr (symbol definitions given in the inset,
n = 7–8).
(D) CE formation. Peritoneal macrophages (n = 7) were
incubated with acLDL and [1-14C]oleate-albumin complex
for 24 hr, and the incorporation of [1-14C]oleate into CE
fraction was measured.
(E) Cholesterol efflux. After labeling of cells (n = 5) with
radiolabeled acLDL, the medium was changed to
DMEM/FCS containing acLDL with or without HDL3. After
24 hr, the radioactivity of an aliquot of the medium and of
the cell lysate was measured. The percent efflux was
calculated as (media dpm)/(cell + media dpm) 3 100.
(F) Microsomal ACAT activity (n = 8). ACAT activity in
microsomes was determined by the rate of incorporation
of [1-14C]oleoyl-CoA into the CE fraction. Data are
expressed as the mean ± SEM. * and ** denote p < 0.05
and p < 0.01, respectively, as determined by ANOVA
followed by the Tukey-Kramer posthoc test.
with wild-type macrophages, whereas the intra-
cellular free cholesterol (FC) content was not
affected by genotype (Figure 1C). The formation
of CE was also monitored by the incorporation
of [14C]oleate into cholesterol oleate, and the
intracellular [14C]cholesterol oleate was accu-
mulated in Nceh1/ macrophages approxi-
mately 2.5-fold compared with wild-type
macrophages (Figure 1D). Cholesterol efflux was reduced by
35% in Nceh1/ macrophages compared with wild-type
macrophages in the presence or absence of high-density lipo-
proteins (HDL)3 (250 mg/ml) as an exogenous lipid acceptor
(Figure 1E). Upon exposure to acLDL, excess cholesterol in
the endoplasmic reticulum (ER) becomes esterified by acyl-
CoA:cholesterol acyltransferase (ACAT) and stored in cyto-
plasmic lipid droplets (LDs) (Chang et al., 2001). The ACAT
activity did not differ between wild-type and Nceh1/ macro-
phages, and the ACAT activity did not explain the excess accu-
mulation of CEs in Nceh1/ macrophages (Figure 1F).
We also investigated the expression profiles of genes involved
in the metabolism of cholesterol and formation of foam cells.
Nceh1 deficiency did not alter the expression profile, while
acLDL loading altered the expression of several genes such
as the Ldlr, ATP-binding cassette transporter A1(Abca1),
3-hydroxy-3-methyl-glutaryl-CoA synthase (Hmgcs1), and class
B scavenger receptor (Scarb1) (Figure S2A). The expression of
Lipe was not affected by Nceh1 deficiency at the mRNA or
protein level (Figures S2B–S2D).
To clarify the importance of Nceh1 in multiple receptor path-
ways, we investigated the effects of two other kinds of modified
lipoproteins: beta very low-density lipoproteins (VLDL) and220 Cell Metabolism 10, 219–228, September 2, 2009 ª2009 Elsevier Inc.
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macrophages were exposed to beta-VLDL or oxLDL, the intra-
cellular CE content was increased by 194%–231% and 150%,
respectively, compared with wild-type macrophages (Figure 2A
for beta-VLDL and Figure 2B for oxLDL). As predicted,
[14C]oleate’s incorporation into intracellular CE was also
increased in Nceh1/ macrophages by 195% and 190%,
respectively, upon exposure to beta-VLDL and oxLDL (Figure 2C
for beta-VLDL and Figure 2D for oxLDL).
Nceh1 Deficiency Aggravates Atherosclerosis
To evaluate the impact of a deficiency of Nceh1 on the develop-
ment of atherosclerotic lesions, Nceh1/ mice were back-
crossed to theC57BL6/J background for at least five generations
andcross-bredwithApoe-deficient (Apoe/)mice. Theoffspring
were fed a western-type diet containing 0.15% (w/w) cholesterol
and 20% (w/w) fat starting at 5 weeks of age for 12 or 16 weeks,
and thedegreeof atherosclerosiswasdeterminedeither byquan-
tifying sudanophilic en face lesions in pinned out aortas (Figures
3A and 3B) or by quantifying Oil Red O-stained lesions in cross-
Figure 2. Foam Cell formation Induced by beta-
VLDL or Oxidized LDL
(A) Peritoneal macrophages (n = 5–6 for each genotype)
were incubated with beta-VLDL (10 or 20 mg/ml) for
24 hr, and intracellular CE content and FC content were
determined. As a control, the same cells were also incu-
bated with acLDL (100 mg/ml) simultaneously.
(B) Peritoneal macrophages (n = 7 for each genotype) were
incubated with oxLDL (50 mg/ml) or acLDL (50 mg/ml) for
24 hr, and intracellular CE content and FC content were
determined.
(C and D) CE formation. Peritoneal macrophages (n = 6–7
for each genotype) were incubated with beta-VLDL (10 or
20 mg/ml, C) or oxidized LDL (oxLDL) (50 mg/ml, D) in the
presence of [1-14C]oleate-albumin complex for 24 hr.
Intracellular lipids were separated by thin layer chroma-
tograpy (TLC), spots corresponding to the CE fraction
were scraped off, and radioactivity was measured. As
a control, the same cells were incubated with acLDL.
Data are expressed as the mean ± SEM. * and ** denote
p < 0.05 and p < 0.01, respectively, as determined by
ANOVA followed by the Tukey-Kramer posthoc test.
sections from the aortic root (Figures 3C and
3D). The areas of the aortic surface covered
by atherosclerotic lesions were increased in
Nceh1/;Apoe/mice compared toNceh1+/+;
Apoe/mice (2.2-fold formales and 2.3-fold for
females at 17 weeks of age, and 1.7-fold for
males and 2.4-fold for females at 21 weeks of
age). The results of the en face analysis were
confirmed by quantification of Oil RedO-stained
aortic root sections (1.8-fold for male and 1.2-
fold for female at 17 weeks of age, and 1.8-fold
for male and 1.6-fold for female at 21 weeks of
age). It is known that the correlation between
the morphometric assessment of lesions and
the content of FC and CE is high (Veniant et al.,
2000); therefore aortic lipids were extracted
and measured (Figure 3E). Consistent with the
increased lesion area in Nceh1/:Apoe/ mice, FC as well as
CE content was significantly higher in Nceh1/;Apoe/ aortas
than Nceh1+/+;Apoe/ aortas (1.5-fold and 1.3-fold increase
for male and female FC content, respectively, and 2.0-fold and
1.3-fold increase for male and female CE content, respectively).
Next, we determinedwhether the deficiency of Nceh1 inApoe/
mice influenced whole-body metabolism. None of the metabolic
parameters (plasma total cholesterol and triglyceridesconcentra-
tions, blood glucose level, and body weight) was affected by the
deficiency (Table S2).
Furthermore, it was confirmed that the deficiency of Nceh1
in Apoe/ mice had no effect on plasma lipoprotein profiles
evaluated by high performance liquid chromatography (HPLC)
(Table S3). Taken together, Nceh1 deficiency accelerated the
development of atherosclerosis without affecting whole-body
metabolism. Immunohistochemistry using the macrophage
marker F4/80 was carried out, and the percentage of macro-
phage-infiltrated area per unit lesion area was not significantly
different between Nceh1+/+;Apoe/ and Nceh1/;Apoe/
mice (Figures 3F and 3G).Cell Metabolism 10, 219–228, September 2, 2009 ª2009 Elsevier Inc. 221
Cell Metabolism
Absence of Nceh1 Accelerates AtherosclerosisBoth Nceh1 and Lipe Mediate nCEH Activity
To characterize the remaining nCEH activity in Nceh1/macro-
phages, we examined whether the expression of Lipe was
induced in Nceh1/ macrophages. The expression of Lipe was
not altered at either the mRNA or protein level irrespective of
the incubation with acLDL (Figures S2A–S2C). We also per-
formed a western blot analysis of individual samples. There
was no significant difference in the expression of Lipe protein
between wild-type and Nceh1/ macrophages (data not
shown). Next, we separated microsomal and cytosolic subcel-
lular fractions by ultracentrifugation. Nceh1 deficiency did not
affect the expression of Lipe protein in the cytosolic or micro-
somal fraction (Figure S2D). To test whether Lipe is responsible
for the remaining nCEH activity in Nceh1/ macrophages,
Nceh1/ mice were cross-bred with Lipe-deficient (Lipe/)
mice to produce mice deficient in both Nceh1 and Lipe
(Nceh1/;Lipe/). The nCEH activity in Nceh1/;Lipe/
macrophages was dramatically reduced, approximately to 10%
of that in wild-type macrophages, and Nceh1 and Lipe were
responsible for approximately 50% of the nCEH activity, respec-
Figure 3. Atherosclerosis in Nceh1/;Apoe/
Mice
(A) Nceh1-deficient mice were crossed with Apoe-defi-
cient mice, and fed aWestern-type diet starting at 5 weeks
of age for 12 weeks. Representative images of pinned
Sudan-IV stained aortas from mice (en face analysis,
Nceh1 genotype, and quantification values indicated).
(B) Quantification of the surface area occupied by the
lesions (% area occupied by the lesions, n = 10–11). The
duration of the dietary load (12 weeks or 16 weeks) and
Nceh1 genotype are indicated below the graphs in (B)
and (D).
(C) Representative photomicrographs of aortic root
cross-sections stained with Oil-Red O. Nceh1 genotype
is indicated above the images.
(D) Quantification of the area occupied by lesions using
cross-sections of aortic roots (n = 10–15). For analyzing
the area occupied by atherosclerotic lesions, both the
Mann-Whitney U test and two-tailed Student’s t test
were used. The P values generated by the two analyses
were consistent.
(E) Extraction of aortic wall lipids. After 12 weeks on
a western-type diet, mice (n = 11–12 for males and n =
14–16 for females) were euthanized and the aortas were
prepared.
(F) Representative photomicrographs of F4/80-stained
aortic root cross-sections from male mice fed a western-
type diet for 12 weeks.
(G) The quantification of the F4/80-stained area (n = 10 for
each genotype). The macrophage lesion area is indicated
as a percentage of the total lesion area. Data are
expressed as the mean ± SEM. * denotes p < 0.05 as
determined with the two-tailed Student’s t test for (E)
and (G) (NS denotes nonsignificant difference).
tively (Figure 4A). Thus, these two lipases were
responsible for the majority of the nCEH activity
in MPMs. Upon subcellular fractionation, Nceh1
contributed solely to the microsomal nCEH
activity, while Lipe contributed to both cytosolic
and microsomal nCEH activity (Figure 4C).
Meanwhile, substantial TGL activity remained even in the
Nceh1/;Lipe/macrophages (Figure 4B) (72%without acLDL
and 83% with acLDL, of that in wild-type macrophages). To
investigate the roles of Nceh1 and Lipe in foam cell formation,
the macrophages of each genotype were incubated with acLDL.
Upon exposure to acLDL, Nceh1 and Lipe deficiency resulted in
an increase of intracellular CE content by 29% and 51%
compared with the wild-type, respectively (Figure 4D). Interest-
ingly, Nceh1 and Lipe contributed in an additive manner to the
intracellular CE content of Nceh1/;Lipe/ macrophages (an
increase of 70% compared with the wild-type, Figure 4D). The
extent of foam cell formation for each genotype was also
confirmed by the incorporation of [14C]oleate into the cellular
CE (Figure 4E).
Although the nCEH activity of Nceh1/ macrophages was
almost identical to that of Lipe/macrophages, Lipe/macro-
phageswere less prone to form foamcells thanNceh1/macro-
phages.Nceh1andLipealsocontributed in anadditivemanner to
cholesterol efflux (Figure 5A, reduction by 11%–5%, 23%–
21%, and 43%–45% in Nceh1+/+;Lipe/, Nceh1/;Lipe+/+,222 Cell Metabolism 10, 219–228, September 2, 2009 ª2009 Elsevier Inc.
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macrophages, respectively). The basal efflux to bovine serum
albumin (BSA) alonewithout an extracellular lipoprotein acceptor
or serum was also examined (Figure 5B). To eliminate the possi-
bility that the constant cycle of hydrolysis and resynthesis of
CE modulates cholesterol efflux, the experiment was conducted
in the presence or absence of an ACAT inhibitor, CS-505. Since
it was reported that the simultaneous cholesterol-loading and
ACAT inhibition led to cytotoxicity in macrophages (Tabas,
2005), macrophages were loaded with acLDL reconstituted
with [3H]cholesteryl linoleate for 24 hr, and the medium was
changed to that without acLDL in the presence or absence of
Figure 4. nCEHActivityandFoamCellFormation inLipe/,Nceh1/,
or Nceh1/;Lipe/ Macrophages
(A and B) Peritoneal macrophages (n = 6–7 for each genotype) were incubated
with or without acLDL (100 mg/ml) for 24 hr, and nCEH (A) and TGL (B) activities
were determined.
(C) The nCEH activity after subcellular fractionation (n = 6–7).
(D) Peritoneal macrophages (n = 8) were incubated with or without acLDL for
24 hr, and intracellular CE content and FC content were measured.
(E) CE formation. Peritoneal macrophages (n = 7–8) were incubated with
acLDL in the presence of [1-14C]oleate-albumin complex for 24 hr, and the
incorporation of [1-14C]oleate into CE fraction was measured. Data are
expressed as the mean ± SEM. * and ** denote p < 0.05 and p < 0.01, respec-
tively, as determined by ANOVA followed by the Tukey-Kramer posthoc test.Cell MeCS-505 or HDL. Under such conditions, cholesterol efflux was
very slow in the absence of HDL and strikingly facilitated by
HDL, and the FC was effluxed from macrophages of each geno-
type in a quite reproducible fashion (Figure 5C). The contributions
of Nceh1 and Lipe to the cholesterol efflux were further verified in
these additional experiments.
ACAT1 is an allosteric enzyme regulated by FC (Chang et al.,
2001), and the hydrolysis of cellular CE would supply substrate
for ACAT. Consistent with this assumption, microsomal ACAT
activity was reduced in Nceh1/;Lipe/ macrophages when
they were loaded with acLDL (45% reduction compared with
wild-type macrophages) (Figure 5D).
We performed a northern blot analysis of the genes involved
in the metabolism of cholesterol during the formation of foam
cells. Cholesterol loading by incubation with acLDL increased
the mRNA expression of Cd36, Abca1, and Abcg1, while it
decreased the mRNA expression of Ldlr. However, there was
no obvious difference in the mRNA expression of the genes
examined among four genotypes under conditions of cholesterol
loading (Figure 5E). We also compared the endocytic uptake and
degradation of acLDL by macrophages of each genotype
(Figure 5F). Supporting the results of the northern blot analysis,
there was no significant difference in the internalization and
degradation of acLDL among the 4 genotypes.
Atheroprotective Role of Nceh1 and Lipe
Deficiency of Lipe or Nceh1 in whole body may affect athero-
sclerosis by the systemic phenotypes irrelevant to the local
phenotypes in macrophages. Indeed, Lipe deficiency changed
glucose tolerance as well as plasma lipoprotein profiles (Table
S4). To specifically assess the biological roles of macrophage
nCEHs in atherogenesis in vivo, we took advantage of bone
marrow transplantation to selectively disrupt the Nceh1 gene
and/or Lipe gene in hematopoietic cells. Female Ldlr-deficient
(Ldlr/) mice were exposed to total-body irradiation to elimi-
nate the endogenous bone marrow-derived cells, and subse-
quently transplanted with bone marrow cells isolated from
male donor mice of each genotype. Successful reconstitution
of recipients with cells of donor origin after bone marrow trans-
plantation was established by PCR-assisted amplification of the
Sry gene (a male marker) and Nceh1 or Lipe mutant gene
(Figure 6A).
During the course of the experiment, a deficiency of Nceh1
and/or Lipe in hematologic cells did not alter serum lipid levels
(Table S5). An analysis using HPLC did not detect any difference
in the cholesterol and triglycerides levels of each lipoprotein frac-
tion (data not shown). The atherosclerotic surface area were
increased by 1.7-fold in Lipe/(BM)/Ldlr/ mice and 3.1-fold
in Nceh1/(BM)/Ldlr/ mice compared to wild-type(BM)/
Ldlr/ mice. The effect was most pronounced in Nceh1/;
Lipe/(BM)/Ldlr/ mice (a 4.3-fold increase compared to
wild-type(BM)/Ldlr/ mice) and was approximately additive
with respect to the contribution (Figures 6B and 6C). Although
the difference between wild-type(BM)/Ldlr/ mice and Lipe/
(BM)/Ldlr/mice was not statistically significant when analyzed
by an one-way ANOVA, it was statistically different when
analyzed by a two-tailed Student’s t test (p = 0.016). Quantifica-
tion of cross-sectional lesion area in aortic root sections further
supported the significance of Nceh1 and Lipe in atherogenesistabolism 10, 219–228, September 2, 2009 ª2009 Elsevier Inc. 223
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Nceh1/, or Nceh1/;Lipe/ Macrophages
(A and B) Cholesterol efflux. Peritoneal macrophages (n =
6, A, n = 6–7, B) were incubated for 24 hr in DMEMcontain-
ing 10% FCS (A) or 5% BSA (B) with acLDL (100 mg/ml)
whose CE was reconstituted with cholesteryl[1,2-3H]lino-
leate. After labeling of the cells, the medium was changed
to DMEM containing 10% FCS (A) or 5% BSA (B) with
acLDL (100 mg/ml)in the presence or absence of HDL3
(250 mg/ml).
(C) Peritoneal macrophages (n = 5–6) were incubated
for 24 hr in DMEM containing 5% BSA with 100 mg/ml
acLDL whose CE was reconstituted with cholesteryl
[1,2-3H]linoleate. After labeling of the cells, the medium
was changed to DMEM containing 5% BSA in the pres-
ence or absence of an ACAT inhibitor, CS-505 (10 mM)
and/or HDL3 (250 mg/ml). After 24 hr, the radioactivity of
an aliquot of the medium and cell lysate was measured.
The percent efflux was calculated as (media dpm)/(cell +
media dpm) 3 100.
(D) Microsomal ACAT activity. Peritoneal macrophages
(n = 6–7) were incubated with or without acLDL (100 mg/ml)
for 24 hr. ACAT activity in microsomes was determined by
the rate of incorporation of [1-14C]oleoyl-CoA into the CE
fraction.
(E) Gene expression profile. Peritoneal macrophages (n =
4) were incubated with or without acLDL (100 mg/ml) for
24 hr. Nceh1, neutral cholesterol ester hydrolase 1; Lipe,
hormone-sensitive lipase; Msr1, type A scavenger
receptor; Scarb1, scavenger receptor class B type-I;
Ldlr, the low-density lipoprotein receptor; Soat1, acyl-
CoA:cholesterol acetyltransferase 1; Abca1, ATP-binding
cassette transporter A1; Abcg1, ATP-binding cassette
transporter G1. Loadingwas normalized by the expression
of Rplp0 (acidic ribosomal phosphoprotein P0).
(F) Cellular uptake and degradation of acLDL. Peritoneal
macrophages (n = 5) were incubated with a medium con-
taining varying concentrations of 125I-acLDL with or
without a 40-fold excess of unlabeled acLDL for 5 hr at
37C. The amounts of 125I-acLDL either degraded by or
associated with the cells were measured. Data are
expressed as the mean ± SEM. * and ** denote p < 0.05
and p < 0.01, respectively, as determined by ANOVA
(AD) or repeated-measures ANOVA (F) followed by the
Tukey-Kramer posthoc test.(a 1.2-fold increase in Lipe/ (BM)/Ldlr/ mice, a 1.6-fold
increase in Nceh1/ (BM)/Ldlr/ mice, and a 2.0-fold increase
in Nceh1/;Lipe/ (BM)/Ldlr/ mice compared to wild-
type(BM)/Ldlr/ mice, respectively (Figures 6D and 6E).
DISCUSSION
The hydrolysis of cellular CEs is the first committed step in the
efflux of cholesterol. Subsequently, cholesterol is transferred
to plasmamembrane where ABCA1 and/or ABCG1mediate final
transfer to apoA-I and/or HDL, respectively. Under normal
circumstances, the efflux of cholesterol mediated by ABC trans-
porters is rate-limiting in the overall process, since the combined
deficiency severely impaired cholesterol efflux (Out et al., 2008;
Wang et al., 2007; Yvan-Charvet et al., 2007), and since choles-
terol efflux was stimulated when the expression of these ABC
transporters were induced by the activation of LXR (Venkates-
waran et al., 2000; Tazoe et al., 2008). Under conditions where224 Cell Metabolism 10, 219–228, September 2, 2009 ª2009 Elsevian excess of cholesterol is stored as CE in LDs of macrophage
foam cells, the hydolysis of cellular CEmay become rate-limiting
as was observed in the present study (Figures 1E and 5A–5C). It
is of note that the deficiency of Nceh1 caused a more profound
decrease in cholesterol efflux than the deficiency of Lipe,
even though the reduction in nCEH activity was comparable
(Figure 4A). These results suggest that the roles of Lipe and
Nceh1 in the mobilization of cholesterol from LDs to the medium
are somewhat different: Nceh1 is more efficient than Lipe in this
process.
Based on our current results, the contribution of the ortholog
of CEH, TGH1, and Ces1, to the nCEH activity of MPM would
be marginal. In contrast to MPMs, human monocyte-derived
macrophages express CEH, a macrophage serine-esterase.
Even in humanmacrophages, CES1 is not amajor enzymemedi-
ating the hydrolysis of CE, and NCEH1 (NM_020792) also plays
a central role in the CE hydrolysis in human macrophages
(M.I., unpublished data).er Inc.
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of the expression of Nceh1 in macrophages can be used
for the treatment or prevention of atherosclerosis. In vitro, we
demonstrated that adenovirus-mediated overexpression of
Nceh1 decreased foam cell formation (Okazaki et al., 2008). To
substantiate these findings, we need to prove the hypothesis
in vivo either by transgenic overexpression of Nceh1 or by its
pharmacological activation. In this context, it is noteworthy
that this hypothesis has been tested by overexpressing
LIPE or CEH to hydrolyze CE in a macrophage-specific manner.
The results for LIPE are somewhat complicated. Over-
expression of LIPE paradoxically increases the development of
atherosclerosis (Escary et al., 1998) and the concomitant co-
overexpression of a cholesterol acceptor, apoA-IV, is anti-athe-
rogenic(Choy et al., 2003). Moreover, overexpression of CES1
was reported to reduce the atherosclerosis of Ldlr/mice(Zhao
et al., 2007).
The human ortholog of Nceh1, KIAA1363, is identical to
human AADACL1 (Probst et al., 1994). Recently, Tiwari et al.
reported that steryl deacetylase 1 in S. cerevisiae, which has
homology to mammalian AADAC and AADACLs, controls the
export of sterols by regulating the deacetylation/acetylation of
cholesterol (Tiwari et al., 2007). In this report, it was shown that
human AADAC, but not AADACL1, catalyzed the deacetylation
Figure 6. Aherosclerosis in Ldlr/ Mice with
Nceh1/, Lipe/, or Nceh1/;Lipe/ Bone
Marrow
(A)Irradiated female Ldlr/ mice (age 8 weeks, n = 12–17)
were transplanted with bone marrow cells isolated from
male wild-type, Lipe/, Nceh1/, Nceh1/;Lipe/
mice (age 8 weeks). Mice were maintained on a chow diet
for the first 4 weeks, then switched to a high-cholesterol
diet. After 12 weeks on the high-cholesterol diet, the mice
were euthanized to assess their lesions. (A) shows verifica-
tion of successful reconstitution with donor hematopoietic
cells by PCR amplification of specific fragments of several
genes. Genomic DNA from bone marrow of chimeric mice
(the genotype of donor mice is indicated below) or tail was
used as a template. The following templates were used as
positive and negative controls (laneA andB): Tail DNA from
aNceh1+/+ andNceh1/mouse forNceh1geneamplifica-
tion, tail DNA from a Lipe+/+ and Lipe/ mouse for Lipe
gene amplification, tail DNA from a Ldlr+/+ and Ldlr/
mouse for Ldlr gene amplification, and tail DNA from
a female andmaleC57BL6/Jmouse forSrygeneamplifica-
tion in lane A and B, respectively.
(B–E) Quantification by en face analysis (B) (quantification
values indicated below the images) (C), and cross-
sectional analysis (D and E). The genotypes of donor cells
are indicated below the graphs. * and ** denote p < 0.05
and p < 0.01, respectively, as determined by ANOVA
followed by the Tukey-Kramer posthoc test.
of acetylated cholesterol. Thus, it is not
surprising that the substrate of AADACL1
(NCEH1) is CE.
In foam cells, CE is the major lipid component
in LDswith triglyceride typically comprising 10%
or less of the total lipid. While Nceh1 and Lipe
were responsible for the majority of the nCEH
activity in macrophages, substantial amount of TGL activity in
macrophages was remained even in the Nceh1/;Lipe/
macrophages. In adipose tissue, adipose triglyceride lipase
(PNPLA2) was identified as a non-Lipe triglyceride lipase, and
Pnpla2 is also expressed in macrophages (Zimmermann et al.,
2008). Pnpla2 might be a promising candidate responsible for
the remaining TGL activity in Nceh1/;Lipe/ macrophages.
It was also reported that KIAA1363 hydrolyzes 2-acetyl mono-
alkylglycerol and the chemical inhibition of KIAA1363 modulates
the metabolism phospholipids such as lysophosphatidinic acid
and platelet-activating factor (Chiang et al., 2006). Lysophos-
phatidinic acid and platelet-activating factor are implicated in
monocyte adhesion and transmigration, and promote athero-
sclerosis through their inflammatory activities (Ninio, 2005).
Thus, it remains possible that the Nceh1 deficiency aggravates
atherosclerosis at least in part by altering the composition of
phospholipids, which have pro-atherogenic or anti-atherogenic
potentials.
In conclusion, Nceh1 plays a crucial role in the development of
both foam cells and atherosclerotic lesions. Nceh1 and Lipe are
two major enzymes with nCEH activity in murine macrophages.
These findings should provide the basis for understanding the
pathophysiology of atherosclerosis and can be exploited to
develop an attractive therapeutic approach.Cell Metabolism 10, 219–228, September 2, 2009 ª2009 Elsevier Inc. 225
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Generation of the Nceh1/ Mice
A replacement-type targeting vector was constructed; the 1 kb short arm
spanning intron 3, and the 10 kb long-arm fragment encompassing intron
4–5 were generated by PCR using genomic DNA from the 129/Sv mouse as
a template. Primers used were as follows; 50-ctcgagatcagctcaaggctggagt
gtg-30 and 50-ctcgagctctttgtaaagtacatgtggccc-30 for the short arm and 50-acct
ttctcacggggttttctgaagtgggt-30 and 50-gcatcctgcctgaatctgcaagtgctgag-30 for
the long arm. After subcloning into pGEM-T easy vector (Promega, Madison,
WI), the fragments were cut out and inserted into the Xho I and Not I sites,
respectively, of pPol II -short-neo-bpA-HSVTK as described previously (Ishi-
bashi et al., 1993). Thus, a 1.2 kb region spanning exon 4 of the Nceh1 gene
was replaced by a neomycin-resistant cassette, which was expected to
abolish translation of the catalytic motif. After linearization by digestion with
SalI, the vector was electroporated into JH1 embryonic stem cells (a gift
from Dr. J Herz). Targeted clones, which had been selected in the presence
of G418 and 1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-5-iodouracil, were
identified by PCR using the following primers; sense (50-gacttgacctcacagtgtgt
gaacc-30 ) and antisense (50- gattgggaagacaatagcaggcatgc-30).
Homologous recombination was verified by Southern blot analysis after
digestion with BglII using a 50-flanking probe. Targeted embryonic stem cell
clones were injected into the C57BL/6J blastocysts yielding two lines of
chimeric mice, which transmitted the disrupted allele through the germ line.
Genotyping was performedwith PCR using specific primers: sense (50-tccagta
gaagagggcacagaggtcc-30 ), antisense (50-ccatcccgtttaccaataaagcttaaggc-30)
and neo (50-aggattgggaagacaatagcaggcat-30).
The genetic background used in this study was as follows: (1) experiments
in vitro usingNceh1/micewere performed onmatched littermates from 129/
Sv-C57BL/6J hybrid descendants (F1 and subsequent generations) unless
otherwise stated. (2) Nceh1/ mice were crossed onto the C57BL/6J back-
ground for more than five generations and then crossed with Apoe/ mice
on a C57BL/6 background (the Jackson Laboratory). (3) Nceh1/ mice
were crossed onto the C57BL/6J background for more than five generations
and then crossed with Lipe/ mice (crossed onto the C57BL6/J background
for more than ten generations) (Osuga et al., 2000) for experiments in vitro
using Nceh1/;Lipe/macrophages. (4) For donor mice in the bone marrow
transplantation experiments, mice were crossed onto the C57BL6/J back-
ground for more than ten generations. Mice were maintained on a 12 h dark/
light cycle and were fed a normal chow diet (Lab Diet 5053, PMI Nutrition Inter-
national) unless otherwise stated. All experimental procedures involving
animals were conducted according to our institutional guidelines.
Bone Marrow Transplantation
To eliminate the endogenous bone marrow-derived cells, female Ldlr/ mice
(age 8 weeks) were exposed to a single dose of 9 Gy total body irradiation.
Irradiated recipients were transplanted with 5 3 106 bone marrow cells, iso-
lated from male wild-type, Lipe/, Nceh1/, and Nceh1/;Lipe/ mice
(age 8 weeks). Mice were maintained on a chow diet for the first 4 weeks,
and then switched to a high-cholesterol diet containing 1.25% (w/w) choles-
terol and 15% (w/w) cocoa butter (Oriental Yeast Company; Tokyo, Japan).
After 12 weeks on the high-cholesterol diet, the chimeras were euthanized
for the assessment of the lesions. The hematologic chimerism of the Ldlr/
mice was determined in genomic DNA from bone marrow by PCR at 12 weeks
posttransplant. Sry-s (50-gtggtgagaggcacaagt-30) and Sry-as (50-gagta-
caggtgtgcagct-30) were used to detect the Sry gene specific to the mouse
Y chromosome(Mignon et al., 1998). The primers used to detect both the
wild-type and the null mutant Nceh1 or Lipe gene were described above or
previously (Osuga et al., 2000).
Peritoneal Macrophages
Thioglycorate-elicited macrophages were obtained from 8 week-old mice as
described previously (Osuga et al., 2000). The cells were resuspended in Dul-
becco’s Modified Eagle Medium (DMEM) to give a concentration of 106 cells
per ml, and 10 ml per dish was plated in 10 cm dishes. Cells were incubated
in DMEM containing 10% fetal calf serum (FCS) in an atmosphere of 5%
CO2 and 95% air unless otherwise stated.226 Cell Metabolism 10, 219–228, September 2, 2009 ª2009 ElseviePreparation of Lipoproteins
After an overnight fast, blood was collected from normolipidemic volunteers
to isolate plasma. LDL (d =1.019–1.063 g/ml) and HDL (d = 1.063–1.21 g/ml)
were isolated from the plasma by sequential density ultracentrifugation
(Havel et al., 1955). LDL was acetylated by repetitive additions of acetic
anhydride (Goldstein et al., 1979). acLDL was radioiodinated with Na125I by
the iodine monochloride method (Goldstein et al., 1979). CE in acLDL was
reconstituted with [1,2-3H]cholesteryl linoleate as described previously
(Roberts et al., 1985). To prepare oxLDL, LDL was incubated for 17 hr at
37C with 5 mM CuSO4, followed by the addition of 2.5 mM EDTA (Sakai
et al., 1996). Beta-VLDL (d = 1.006–1.019 g/ml) was isolated by sequential
ultracentrifugation of plasma obtained from overnight fasted male Japanese
White rabbits maintained on a cholesterol-enriched diet containing 1% (w/w)
cholesterol.
Determination of Cholesterol Content
Cellular lipids were extracted by hexane/isopropyl alcohol, and cholesterol
content was determined by an enzymatic fluorometric microassay according
to the method of Heider and Boyett, with minor modifications (Heider and
Boyett, 1978; Yagyu et al., 2000).
CE Formation
The amounts of CE formed from [1-14C]oleic acid was determined as
described previously with minor modifications (Perrey et al., 2001).
TGL and nCEH Activity Assay
Enzymatic activity was assayed as described previously (Osuga et al., 2000;
Sekiya et al., 2008). The sampleswere incubated at 37C for 30–60min in a final
volume of 200 ml of a reaction mixture containing 105 mmol/l tri[3H]oleoylgly-
cerol (99.4 mCi/mmol), 23.7 mmol/l lecithin, 12.5 mmol/l sodium taurocholate,
1 mol/l NaCl, and 85 mmol/l potassium phosphate (pH 7.0). The high concen-
tration of NaCl was included to inactivate lipoprotein lipase. The nCEH activity
was measured using a reaction mixture containing 6.14 mmol/l cholesterol
[1-14C]oleate (48.8 mCi/mmol).
Cholesterol Efflux
Cholesterol efflux assays were performed as described previously (Roberts
et al., 1985). Cells were incubated for 24 hr at 37C in DMEM containing
bovine serum albumin (BSA, 5 mg/ml) or 10% FCS and acLDL (100 mg/ml)
whose CE was reconstituted with [1,2-3H]cholesteryl linoleate. After labeling
of the cells, the medium was changed to DMEM containing BSA (5 mg/ml) or
10% FCS with acLDL (100 mg/ml) and with/without HDL3 (250 mg/ml). After
24 hr, an aliquot of the medium was removed and centrifuged at 15,000 3
g for 2 min to remove cellular debris, and the radioactivity in the supernatant
was measured with a liquid scintillation counter. The cells were lysed in 0.1 N
NaOH, and the radioactivity in an aliquot of the cell lysate was measured.
The percent efflux was calculated as (media dpm)/(cell + media dpm) 3
100. To precisely evaluate the contribution of nCEH activity to cholesterol
efflux, additional assays were conducted in the presence of the ACAT inhib-
itor CS-505 (provided by Daiichi Sankyo and Kyoto pharmaceutical indus-
tries) (Takahashi et al., 2008). After cells were loaded with cholesterol for
24 hr by incubation with acLDL, whose CE was reconstituted with
[1,2-3H]cholesteryl linoleate, the medium was changed to DMEM containing
BSA (5 mg/ml) in the presence or absence of CS-505 (10 mM) or HDL3
(250 mg/ml). After incubation for 24 hr, the radioactivity in media and cells
was measured.
Microsomal ACAT Activity
Cells were sonicated in buffer A (20 mM Tris-HCl pH 7.0, 250 mM sucrose,
5 mg/ml leupeptin, and 2.8 mg/ml aprotinin), ultracentrifuged at 100,000 3 g
for 45 min at 4C, and re-ultracentrifuged at 100,000 3 g for 45 min at 4C.
The precipitates were resuspended and used for the assay. ACAT activity in
microsomes was determined by the rate of incorporation of [1-14C]oleoyl-
CoA into the CE fraction according to Yagyu et al. (Yagyu et al., 2000).
Cellular Uptake and Degradation of 125I-AcLDL
Peritoneal macrophages were plated in 12-well plates at a density of 1 3 106/
well and incubated with a medium containing varying concentrations ofr Inc.
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5 hr, the amounts of 125I-AcLDL either degraded by or associated with the cells
were measured according to a modified method of Goldstein (Goldstein et al.,
1983; Perrey et al., 2001).
Northern Blot Analysis
Total RNA was isolated using Trizol Reagent (Life Technologies; Helgerman,
CT). Ten microgram RNA samples equally pooled from each genotype were
electrophoresed in a 1% agarose gel containing formaldehyde and transferred
to a nylon membrane. The membranes were hybridized with probes, which
were labeled with [a-32P]dCTP using a Megaprime DNA Labeling System Kit
(Amersham Biosciences; Piscataway, NJ) in Rapid-hyb Buffer (Amersham
Biosciences) or Ultra-hyb buffer (for HSL mRNA detection) (Ambion; Austin,
TX) and analyzed using a BAS2000 Bioimaging Analyzer (Fuji Photo Film;
Tokyo, Japan). Loading was normalized by the expression of Rplp0 (acidic
ribosomal phosphoprotein P0) mRNA.
Quantitative Real-Time PCR
Twomicrograms of total RNAwas reverse-transcribed using the ThermoScript
RT-PCR System (Invitrogen). Quantitative real-time PCR was performed using
SYBR Green Dye (Applied Biosystems; Foster City, CA) in an ABI Prism 7900
PCR instrument (Applied Biosystems). The relative abundance of each
transcript was calculated from a standard curve of cycle thresholds for serial
dilutions of a cDNA sample and normalized to Rplp0. Primer sequences are
available upon request.
Measurement of Atherosclerotic Lesions
Nceh1/;Apoe/ mice and littermate Nceh1+/+;Apoe/ mice were fed
a western-type diet containing 0.15% (w/w) cholesterol and 20% (w/w) fat
(Oriental Yeast Company; Tokyo, Japan). (2) Bone marrow chimeric Ldlr-defi-
cient micewere fed the high-cholesterol diet. After the indicate time, they were
euthanized and their hearts and aortas were isolated. The degree of athero-
sclerosis was assessed by determining lesion sizes on both pinned-open
aortas and serial cross-sections through the aortic root (Paigen et al., 1987;
Yagyu et al., 2000). The aorta was opened longitudinally along the ventral
midline from the iliac arteries to the aortic root. After branching vessels were
removed, the aorta was pinned out flat on a black wax surface. The lesions
were stained with Sudan IV for 15 min, destained with 70% ethanol, and
then fixed in 4% phosphate-buffered formalin. Aortic images were analyzed
with Adobe Photoshop 7 software (Adobe Systems, Incorporated; Mountain
View, CA). Data are reported as the percentage of the aortic surface covered
by lesions (total surface area of the atherosclerotic lesions divided by the total
surface area of the aorta). The hearts were perfused with saline containing 4%
(w/v) formalin and fixed for more than 48 hr in the same solution. The basal half
of the hearts was embedded in Tissue-Tek OCT compound (Miles, Incorpo-
rated), and serial sections were captured using a Cryostat microtome (10 mm
thick). Four sections were used to evaluate the lesions: two at the end of the
aortic sinus and two at the junction of the sinus and ascending aorta. The
sections were stained with Oil Red O and counterstained with hematoxylin.
Immunohistochemistry
Sections were incubated with primary antibody tomouse F4/80 (1:20; Serotec,
Raleigh, NC) for 2 hr. After washes, the sections were incubated with biotiny-
lated anti-rat antibody for 30 min at room temperature and then with avidin-
biotin peroxidase complex (Vector Labs) for 30 min. Finally, the sections
were developed with DAB (Wako Pure Chemicals Co.; Osaka, Japan) and
counterstained with methylgreen.
Extraction of Aortic Wall Lipids
After 12 weeks on a western-type diet, mice were euthanized and the aortas
were prepared. After the removal of connective tissue and fat, lipids were
extracted by the chloroform-methanol method, and FC content and CE
content were measured.
Statistics
Statistical differences between groups were analyzed by one-way analysis of
variance and the post hoc Tukey-Kramer test, unless otherwise stated.Cell MSUPPLEMENTAL DATA
The Supplemental Data include five tables and two figures and can be found
with this article online at http://www.cell.com/cellmetabolism/supplemental/
S1550-4131(09)00233-2.
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